These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 37564159
1. 0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects. Hosseini K, Gollamudi S, Reiser H, Walters T, Lindstrom RL. Clin Ophthalmol; 2023; 17():2219-2230. PubMed ID: 37564159 [Abstract] [Full Text] [Related]
12. Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery. Rajpal RK, Roel L, Siou-Mermet R, Erb T. J Cataract Refract Surg; 2013 Feb; 39(2):158-67. PubMed ID: 23218817 [Abstract] [Full Text] [Related]
13. Prophylactic effectiveness of tobramycin-dexamethasone eye drops compared with tobramycin/vehicle eye drops in controlling post-surgical inflammation in cataract patients : prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre study. Notivol R, Amin D, Whitling A, Wells D, Kennedy M, Cockrum PC, International TobraDex Study Group. Clin Drug Investig; 2004 Feb; 24(9):523-33. PubMed ID: 17523714 [Abstract] [Full Text] [Related]
14. Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery. Fong R, Silverstein BE, Peace JH, Williams JI, Vittitow JL. J Cataract Refract Surg; 2018 Oct; 44(10):1220-1229. PubMed ID: 30193927 [Abstract] [Full Text] [Related]
15. Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study. Trattler W, Hosseini K. Ophthalmol Ther; 2017 Dec; 6(2):277-284. PubMed ID: 28819932 [Abstract] [Full Text] [Related]
17. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial. Colin J, Paquette B. Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464 [Abstract] [Full Text] [Related]
19. Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial. Kim S, Ko BY, Koh JW, Kim EC, Kim HK, Shin YJ, Song JS, Lee DH, Lee JE, Lee HK, Chung SH, Kim HS. J Cataract Refract Surg; 2022 Jun 01; 48(6):710-716. PubMed ID: 34629379 [Abstract] [Full Text] [Related]